MORGAN STANLEY - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 133 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$14,656,298
+145.2%
573,632
+175.2%
0.00%0.0%
Q2 2023$5,977,398
+112.1%
208,417
+77.3%
0.00%
Q1 2023$2,818,273
+37.8%
117,575
-2.5%
0.00%
Q4 2022$2,045,851
+63.1%
120,628
+42.6%
0.00%
Q3 2022$1,254,000
-74.5%
84,586
-72.9%
0.00%
-100.0%
Q2 2022$4,913,000
-34.9%
312,211
+11.5%
0.00%0.0%
Q1 2022$7,548,000
+48.2%
279,970
+103.5%
0.00%0.0%
Q4 2021$5,093,000
-22.5%
137,579
+0.0%
0.00%0.0%
Q3 2021$6,573,000
-21.5%
137,575
-44.4%
0.00%0.0%
Q2 2021$8,377,000
+129.1%
247,544
+179.6%
0.00%0.0%
Q1 2021$3,656,000
+107.5%
88,525
+117.9%
0.00%
Q4 2020$1,762,000
+23.1%
40,625
+21.8%
0.00%
Q3 2020$1,431,000
-79.9%
33,356
-78.1%
0.00%
-100.0%
Q2 2020$7,117,000
+158.9%
152,262
-24.7%
0.00%
+100.0%
Q1 2020$2,749,000
+59.3%
202,239
+27.4%
0.00%
Q4 2019$1,726,000
+112.6%
158,742
+100.9%
0.00%
Q3 2019$812,000
+99.0%
79,030
+83.0%
0.00%
Q2 2019$408,00043,1900.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q1 2022
NameSharesValueWeighting ↓
Tri Locum Partners LP 208,886$5,337,0371.71%
Portolan Capital Management 276,505$7,064,7030.66%
Nikko Asset Management Americas, Inc. 1,388,574$35,422,5230.42%
Green Alpha Advisors, LLC 21,538$550,2960.42%
SummerHaven Investment Management, LLC 22,326$570,4290.42%
ARK Investment Management 1,901,546$48,584,5080.37%
Granahan Investment Management 398,862$10,190,9240.36%
FEDERATED HERMES, INC. 4,711,512$120,379,1320.32%
Woodline Partners LP 1,069,814$27,333,7480.32%
Diametric Capital, LP 26,130$667,6210.28%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders